Participant | Sex | IQ | Depression diagnoses | Co-morbid diagnoses | Medication | Diagnostic instrument | Pre-test | Post-test | Follow-up test |
---|---|---|---|---|---|---|---|---|---|
1 | F | 97 | F32.2 | - | - | CDRS-R | 65 | 55 | 36 |
BDI-II | - | 17 | 15 | ||||||
2 | M | 102 | F32.1 | - | - | CDRS-R | 48 | 43 | 43 |
BDI-II | 9 | 9 | 9 | ||||||
3 | F | 95 | F32.1 | - | - | CDRS-R | 57 | 53 | 49 |
BDI-II | 28 | 28 | 15 | ||||||
4 | F | 94 | F32.1 | - | - | CDRS-R | 52 | 45 | 49 |
BDI-II | 33 | 30 | 30 | ||||||
5 | F | 94 | F32.2 | - | - | CDRS-R | 72 | 56 | 34 |
BDI-II | 39 | 38 | 20 | ||||||
6 | F | 92 | F32.1 | - | - | CDRS-R | 50 | 63 | 58 |
BDI-II | 39 | 30 | 28 | ||||||
7 | M | 100 | F32.2 | - | - | CDRS-R | 61 | 60 | 61 |
BDI-II | 17 | 26 | 20 | ||||||
8 | F | 102 | F32.0 | - | - | CDRS-R | 40 | 30 | 30 |
BDI-II | 8 | 3 | 4 | ||||||
9 | F | 100 | F32.2 | F40.1 | - | CDRS-R | 63 | 49 | Drop out |
BDI-II | 44 | 47 | |||||||
10 | F | 114 | F32.0 | - | - | CDRS-R | 36 | 37 | 23 |
BDI-II | 3 | 1 | 0 | ||||||
11 | F | 111 | F33.0 | - | - | CDRS-R | 45 | 27 | 18 |
BDI-II | 34 | 19 | 3 | ||||||
12 | F | 106 | F32.0 | F40.1 | - | CDRS-R | 45 | 31 | 30 |
BDI-II | 15 | 8 | 7 | ||||||
13 | F | 100 | F32.1 | - | - | CDRS-R | 64 | 48 | 58 |
BDI-II | 23 | 20 | 23 | ||||||
14 | M | 111 | F32.1 | - | Fluoxetin | CDRS-R | 60 | 32 | Drop out |
BDI-II | 42 | 6 | |||||||
15 | M | 104 | F32.1 | F40.1 | St. John’s wort | CDRS-R | 49 | 60 | Drop out |
BDI-II | 39 | 28 |